Skip to main content

Want a detailed portfolio tracker?

Cabaletta Bio (CABA) P/E (2019 - 2026)

Cabaletta Bio (CABA) P/E from Dec 31, 2019 to Jul 21, 2026. The TTM Cabaletta Bio (CABA) P/E is -2.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cabaletta Bio (CABA)

YearP/EChange
2026-2.05+44.66%
2025-1.41-1.44%
2024-1.44-92.38%
2023-18.85+141.09%
2022-7.82+140.89%
2021-3.25-75.85%
2020-13.44-85.52%
2019-92.80N/A

Comparison Cabaletta Bio (CABA) P/E with competitors

Cabaletta Bio (CABA) P/E is -2.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.21%
ENLVEnlivex Ltd0.07-103.65%
FGENFibroGen Inc0.24-111.73%
CHRSCoherus Biosciences Inc0.85-141.45%
FBIOFortress Biotech Inc0.95-146.36%
ORMPOramed Pharmaceuticals Inc1.50-173.43%
AGENAgenus Inc3.01-247.03%
INVAInnoviva Inc3.15-254.08%
VXRTVaxart Inc3.55-273.41%
CRMDCorMedix Inc3.63-277.26%
CVACCureVac N.V.4.45-317.18%
GLPGGalapagos NV4.86-337.37%
SRPTSarepta Therapeutics Inc4.88-338.50%
ABEOAbeona Therapeutics Inc5.39-363.19%
ABUSArbutus Biopharma Corp5.60-373.36%
ZVRAZevra Therapeutics Inc5.89-387.61%
SPROSpero Therapeutics Inc6.23-404.27%
CGENCompugen Ltd6.31-408.45%
RIGLRigel Pharmaceuticals6.87-435.72%
SLXNSilexion Therapeutics Corp7.30-456.43%
OMEROmeros Corporation9.26-552.31%
AUPHAurinia Pharmaceuticals Inc9.58-568.25%
PLXProtalix BioTherapeutics Inc10.89-632.05%
ACADAcadia Pharmaceuticals Inc11.73-672.97%
TBPHTheravance Biopharma Inc12.26-699.04%
ADMAAdma Biologics Inc12.42-706.66%
HRMYHarmony Biosciences Holdings Inc13.82-775.15%
SABSSAB Biotherapeutics Inc14.14-790.59%
NAGENiagen Bioscience Inc14.82-823.90%
INCYIncyte Corp15.82-872.97%
REGNRegeneron Pharmaceuticals Inc15.86-874.64%
PBYIPuma Biotechnology Inc17.32-945.92%
CPRXCatalyst Pharmaceuticals Inc17.44-951.96%
EXELExelixis Inc17.54-956.78%
TGTXTG Therapeutics Inc18.97-1026.54%
MDXGMimedx Group Inc20.55-1104.05%
XOMAXOMA Royalty Corp22.87-1217.52%
ARGXArgen X SE24.30-1287.05%
CTMXCytomX Therapeutics Inc24.82-1312.61%
XOMAOXOMA Royalty Corp25.34-1338.19%
HALOHalozyme Therapeutics Inc25.62-1351.82%
XOMAPXOMA Royalty Corp25.67-1354.09%
VRTXVertex Pharmaceuticals Inc27.99-1467.65%
RPRXRoyalty Pharma plc - Class A28.69-1501.50%
SLNOSoleno Therapeutics Inc29.02-1517.51%
ASNDAscendis Pharma A/S30.09-1569.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1952.15%
APLSApellis Pharmaceuticals Inc39.02-2006.34%
BMRNBiomarin Pharmaceutical Inc42.21-2162.22%
KRYSKrystal Biotech Inc45.34-2315.21%
ONCBeiGene Ltd69.54-3497.33%
PHARPharming Group N.V.75.03-3765.30%
TECHBio-Techne Corp101.96-5081.08%
VCELVericel Corp109.92-5470.10%
ALNYAlnylam Pharmaceuticals Inc117.96-5863.07%
GMABGenmab140.29-6953.77%
TLXTelix Pharmaceuticals Ltd162.15-8021.82%
CORTCorcept Therapeutics Inc212.86-10498.94%